Search This Blog

Friday, November 8, 2019

Sutro Biopharma EPS beats by $0.09, beats on revenue

Sutro Biopharma (NASDAQ:STRO): Q3 GAAP EPS of -$0.56 beats by $0.09.
Revenue of $12.28M (+56.6% Y/Y) beats by $2.41M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)